Catalyst Wire Dossier Catalyst Wire Dossier

Epigenetic and Sensitising Therapy (combination)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epigenetic and Sensitising Therapy (combination), covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS [Phase 1]

See pricing